GSK/Theravance Target 2008 Phase III Start For Next-Gen Bronchodilators
This article was originally published in The Pink Sheet Daily
Executive Summary
Two compounds stemming from the collaboration given once daily were equivalent to salmeterol twice daily in Phase IIb clinical studies.